Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Vertex Pharmaceuticals
(NQ:
VRTX
)
454.97
+6.35 (+1.42%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Mar 25, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
1,199,777
Open
449.14
Bid (Size)
452.00 (40)
Ask (Size)
462.50 (40)
Prev. Close
448.62
Today's Range
449.14 - 459.37
52wk Range
362.50 - 513.98
Shares Outstanding
259,428,394
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Where Will Vertex Pharmaceuticals Be in 1 Year?
↗
Today 16:22 EDT
The biotech's recent dip might be a buying opportunity.
Via
The Motley Fool
CRISPR Therapeutics Stock: Is It a Bargain Buy Right Now?
↗
March 23, 2026
The gene-editing stock has been in a tailspin of late.
Via
The Motley Fool
Performance
YTD
+0.6%
+0.6%
1 Month
-5.4%
-5.4%
3 Month
-0.9%
-0.9%
6 Month
+19.8%
+19.8%
1 Year
-11.1%
-11.1%
More News
Read More
New to The Street Announces Broadcast of Show #739 on Bloomberg Television Across the U.S. at 6:30 PM EST
March 21, 2026
Via
ACCESS Newswire
Vertex Pharmaceuticals (VRTX): The Evolution of a Biotech Powerhouse in 2026
March 20, 2026
Via
Finterra
Topics
Intellectual Property
Vertex Pharmaceuticals Inc (NASDAQ:VRTX) Merges Strong Fundamentals with Bullish Technical Setup
↗
March 13, 2026
Via
Chartmill
Is CRISPR Therapeutics Stock a Buy Now?
↗
March 20, 2026
Via
The Motley Fool
My Top 3 Drug Stocks for March 2026
↗
March 20, 2026
Via
The Motley Fool
Topics
Intellectual Property
Best Growth Stock to Buy Right Now: Eli Lilly vs. Vertex Pharmaceuticals
↗
March 19, 2026
Via
The Motley Fool
Topics
Artificial Intelligence
Curious about which S&P500 stocks are generating unusual volume on Tuesday? Find out below.
↗
March 10, 2026
Via
Chartmill
Q4 Earnings Outperformers: Vertex Pharmaceuticals (NASDAQ:VRTX) And The Rest Of The Therapeutics Stocks
March 17, 2026
Via
StockStory
Topics
Artificial Intelligence
1 Momentum Stock to Research Further and 2 We Ignore
March 16, 2026
Via
StockStory
Is Vertex Pharmaceuticals Heading to $600?
↗
March 15, 2026
Via
The Motley Fool
This Stock Just Jumped By 8%: Is It Too Late to Buy?
↗
March 13, 2026
Via
The Motley Fool
2 Reasons to Watch VRTX and 1 to Stay Cautious
March 13, 2026
Via
StockStory
Topics
Stocks
Vertex Pharmaceuticals Surges 8.3% as Renal Breakthrough Sparks Market Rally
March 11, 2026
Via
MarketMinute
Topics
Stocks
Stocks making big moves yesterday: nLIGHT, Myriad Genetics, Vertex Pharmaceuticals, Nextpower, and Teladoc
March 11, 2026
Via
StockStory
Topics
Artificial Intelligence
Explore the top gainers and losers within the S&P500 index in today's session.
↗
March 10, 2026
Via
Chartmill
Why Vertex Pharmaceuticals (VRTX) Stock Is Up Today
March 10, 2026
Via
StockStory
Topics
Economy
The Great Biotech Divide: Vertex Soars on Multi-Franchise Breakthroughs as Novo Nordisk Stumbles in the Weight-Loss War
March 10, 2026
Via
MarketMinute
Vertex Pharmaceuticals Surges as Breakthrough Kidney Data Sets New Gold Standard for IgA Nephropathy
March 10, 2026
Via
MarketMinute
Which S&P500 stocks are moving on Tuesday?
↗
March 10, 2026
Via
Chartmill
Top S&P500 movers in Tuesday's pre-market session
↗
March 10, 2026
Via
Chartmill
Nasdaq, S&P 500 Futures Turn Green On Iran War De-Escalation Signals: Why NVDA, ORCL, JOBY, VRTX, ZVRA Are On Traders' Radar Today
↗
March 10, 2026
Via
Stocktwits
Topics
Artificial Intelligence
ETFs
Government
VRTX Soars In Extended Hours After Experimental Drug Shows Positive Changes In Autoimmune Kidney Disease
↗
March 09, 2026
Via
Stocktwits
Vertex Announces Positive Week 36 Interim Analysis Results for Primary and All Secondary Endpoints in the RAINIER Phase 3 Trial of Povetacicept in Adults With IgA Nephropathy
March 09, 2026
From
Vertex Pharmaceuticals Incorporated
Via
Business Wire
Frequently Asked Questions
Is Vertex Pharmaceuticals publicly traded?
Yes, Vertex Pharmaceuticals is publicly traded.
What exchange does Vertex Pharmaceuticals trade on?
Vertex Pharmaceuticals trades on the Nasdaq Stock Market
What is the ticker symbol for Vertex Pharmaceuticals?
The ticker symbol for Vertex Pharmaceuticals is VRTX on the Nasdaq Stock Market
What is the current price of Vertex Pharmaceuticals?
The current price of Vertex Pharmaceuticals is 454.97
When was Vertex Pharmaceuticals last traded?
The last trade of Vertex Pharmaceuticals was at 03/25/26 04:00 PM ET
What is the market capitalization of Vertex Pharmaceuticals?
The market capitalization of Vertex Pharmaceuticals is 118.03B
How many shares of Vertex Pharmaceuticals are outstanding?
Vertex Pharmaceuticals has 118B shares outstanding.
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
